nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—ALOX5—Sulfasalazine—ankylosing spondylitis	0.457	0.508	CbGbCtD
Montelukast—PTGS1—Sulfasalazine—ankylosing spondylitis	0.103	0.114	CbGbCtD
Montelukast—CYP2A6—Prednisolone—ankylosing spondylitis	0.102	0.113	CbGbCtD
Montelukast—CYP2A6—Dexamethasone—ankylosing spondylitis	0.06	0.0667	CbGbCtD
Montelukast—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0317	0.0353	CbGbCtD
Montelukast—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0296	0.0329	CbGbCtD
Montelukast—CYP3A4—Triamcinolone—ankylosing spondylitis	0.024	0.0267	CbGbCtD
Montelukast—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0206	0.0229	CbGbCtD
Montelukast—CYP3A4—Betamethasone—ankylosing spondylitis	0.0206	0.0229	CbGbCtD
Montelukast—CYP3A4—Prednisolone—ankylosing spondylitis	0.0203	0.0226	CbGbCtD
Montelukast—CYP3A4—Prednisone—ankylosing spondylitis	0.0192	0.0214	CbGbCtD
Montelukast—CYP3A4—Dexamethasone—ankylosing spondylitis	0.012	0.0133	CbGbCtD
Montelukast—Irritability—Dexamethasone—ankylosing spondylitis	0.000484	0.00479	CcSEcCtD
Montelukast—Irritability—Betamethasone—ankylosing spondylitis	0.000484	0.00479	CcSEcCtD
Montelukast—Asthma—Triamcinolone—ankylosing spondylitis	0.000483	0.00478	CcSEcCtD
Montelukast—Influenza—Triamcinolone—ankylosing spondylitis	0.000483	0.00478	CcSEcCtD
Montelukast—Injury—Prednisone—ankylosing spondylitis	0.00048	0.00476	CcSEcCtD
Montelukast—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000473	0.00469	CcSEcCtD
Montelukast—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000472	0.00468	CcSEcCtD
Montelukast—Bronchitis—Triamcinolone—ankylosing spondylitis	0.000464	0.0046	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000459	0.00454	CcSEcCtD
Montelukast—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.000455	0.00451	CcSEcCtD
Montelukast—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000449	0.00444	CcSEcCtD
Montelukast—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00043	0.00425	CcSEcCtD
Montelukast—Infestation—Methylprednisolone—ankylosing spondylitis	0.00043	0.00425	CcSEcCtD
Montelukast—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000422	0.00418	CcSEcCtD
Montelukast—Irritability—Prednisone—ankylosing spondylitis	0.000421	0.00417	CcSEcCtD
Montelukast—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000421	0.00417	CcSEcCtD
Montelukast—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.000418	0.00414	CcSEcCtD
Montelukast—Epistaxis—Triamcinolone—ankylosing spondylitis	0.000406	0.00402	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000389	0.00386	CcSEcCtD
Montelukast—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000387	0.00384	CcSEcCtD
Montelukast—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000387	0.00383	CcSEcCtD
Montelukast—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000384	0.0038	CcSEcCtD
Montelukast—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000384	0.0038	CcSEcCtD
Montelukast—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000383	0.00379	CcSEcCtD
Montelukast—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000383	0.00379	CcSEcCtD
Montelukast—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00038	0.00376	CcSEcCtD
Montelukast—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00038	0.00376	CcSEcCtD
Montelukast—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000379	0.00375	CcSEcCtD
Montelukast—Pancreatitis—Prednisone—ankylosing spondylitis	0.000374	0.0037	CcSEcCtD
Montelukast—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000358	0.00354	CcSEcCtD
Montelukast—Irritability—Methotrexate—ankylosing spondylitis	0.000352	0.00349	CcSEcCtD
Montelukast—Hallucination—Dexamethasone—ankylosing spondylitis	0.000349	0.00346	CcSEcCtD
Montelukast—Hallucination—Betamethasone—ankylosing spondylitis	0.000349	0.00346	CcSEcCtD
Montelukast—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000348	0.00345	CcSEcCtD
Montelukast—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000348	0.00344	CcSEcCtD
Montelukast—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000338	0.00335	CcSEcCtD
Montelukast—Angioedema—Prednisolone—ankylosing spondylitis	0.000334	0.00331	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000333	0.0033	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000332	0.00329	CcSEcCtD
Montelukast—Asthma—Methotrexate—ankylosing spondylitis	0.000319	0.00316	CcSEcCtD
Montelukast—Convulsion—Prednisolone—ankylosing spondylitis	0.000317	0.00314	CcSEcCtD
Montelukast—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000316	0.00313	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000313	0.0031	CcSEcCtD
Montelukast—Angioedema—Triamcinolone—ankylosing spondylitis	0.000307	0.00304	CcSEcCtD
Montelukast—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000307	0.00304	CcSEcCtD
Montelukast—Hallucination—Prednisone—ankylosing spondylitis	0.000304	0.00301	CcSEcCtD
Montelukast—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.0003	0.00297	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000299	0.00296	CcSEcCtD
Montelukast—Oedema—Prednisolone—ankylosing spondylitis	0.000299	0.00296	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000296	0.00293	CcSEcCtD
Montelukast—Cough—Triamcinolone—ankylosing spondylitis	0.000294	0.00291	CcSEcCtD
Montelukast—Convulsion—Triamcinolone—ankylosing spondylitis	0.000292	0.00289	CcSEcCtD
Montelukast—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000291	0.00288	CcSEcCtD
Montelukast—Myalgia—Triamcinolone—ankylosing spondylitis	0.000286	0.00284	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—ankylosing spondylitis	0.000286	0.00283	CcSEcCtD
Montelukast—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000286	0.00283	CcSEcCtD
Montelukast—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000286	0.00283	CcSEcCtD
Montelukast—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000285	0.00282	CcSEcCtD
Montelukast—Infestation—Methotrexate—ankylosing spondylitis	0.000284	0.00282	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—ankylosing spondylitis	0.000284	0.00282	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000284	0.00282	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000284	0.00281	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000282	0.00279	CcSEcCtD
Montelukast—Angioedema—Dexamethasone—ankylosing spondylitis	0.000279	0.00276	CcSEcCtD
Montelukast—Angioedema—Betamethasone—ankylosing spondylitis	0.000279	0.00276	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000276	0.00274	CcSEcCtD
Montelukast—Immune system disorder—Prednisone—ankylosing spondylitis	0.000276	0.00273	CcSEcCtD
Montelukast—Oedema—Triamcinolone—ankylosing spondylitis	0.000275	0.00272	CcSEcCtD
Montelukast—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000275	0.00272	CcSEcCtD
Montelukast—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000274	0.00271	CcSEcCtD
Montelukast—Infection—Triamcinolone—ankylosing spondylitis	0.000273	0.0027	CcSEcCtD
Montelukast—Infection—Methylprednisolone—ankylosing spondylitis	0.000272	0.0027	CcSEcCtD
Montelukast—Insomnia—Prednisolone—ankylosing spondylitis	0.00027	0.00267	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000269	0.00266	CcSEcCtD
Montelukast—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000269	0.00266	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—ankylosing spondylitis	0.000268	0.00266	CcSEcCtD
Montelukast—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000268	0.00266	CcSEcCtD
Montelukast—Mental disorder—Prednisone—ankylosing spondylitis	0.000268	0.00265	CcSEcCtD
Montelukast—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000266	0.00264	CcSEcCtD
Montelukast—Convulsion—Betamethasone—ankylosing spondylitis	0.000265	0.00262	CcSEcCtD
Montelukast—Convulsion—Dexamethasone—ankylosing spondylitis	0.000265	0.00262	CcSEcCtD
Montelukast—Myalgia—Dexamethasone—ankylosing spondylitis	0.00026	0.00257	CcSEcCtD
Montelukast—Myalgia—Betamethasone—ankylosing spondylitis	0.00026	0.00257	CcSEcCtD
Montelukast—Anxiety—Betamethasone—ankylosing spondylitis	0.000259	0.00256	CcSEcCtD
Montelukast—Anxiety—Dexamethasone—ankylosing spondylitis	0.000259	0.00256	CcSEcCtD
Montelukast—Pain—Prednisolone—ankylosing spondylitis	0.000255	0.00253	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—ankylosing spondylitis	0.000255	0.00253	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000253	0.00251	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000252	0.0025	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00025	0.00248	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00025	0.00248	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00025	0.00247	CcSEcCtD
Montelukast—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000249	0.00247	CcSEcCtD
Montelukast—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000249	0.00247	CcSEcCtD
Montelukast—Oedema—Dexamethasone—ankylosing spondylitis	0.000249	0.00247	CcSEcCtD
Montelukast—Oedema—Betamethasone—ankylosing spondylitis	0.000249	0.00247	CcSEcCtD
Montelukast—Insomnia—Triamcinolone—ankylosing spondylitis	0.000248	0.00246	CcSEcCtD
Montelukast—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000248	0.00245	CcSEcCtD
Montelukast—Infection—Betamethasone—ankylosing spondylitis	0.000248	0.00245	CcSEcCtD
Montelukast—Infection—Dexamethasone—ankylosing spondylitis	0.000248	0.00245	CcSEcCtD
Montelukast—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000247	0.00244	CcSEcCtD
Montelukast—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000246	0.00244	CcSEcCtD
Montelukast—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000244	0.00242	CcSEcCtD
Montelukast—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000244	0.00242	CcSEcCtD
Montelukast—Agitation—Prednisone—ankylosing spondylitis	0.000244	0.00242	CcSEcCtD
Montelukast—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000244	0.00242	CcSEcCtD
Montelukast—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000244	0.00242	CcSEcCtD
Montelukast—Angioedema—Prednisone—ankylosing spondylitis	0.000243	0.00241	CcSEcCtD
Montelukast—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000242	0.00239	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000241	0.00239	CcSEcCtD
Montelukast—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000241	0.00239	CcSEcCtD
Montelukast—Urticaria—Prednisolone—ankylosing spondylitis	0.000237	0.00235	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000237	0.00235	CcSEcCtD
Montelukast—Fatigue—Triamcinolone—ankylosing spondylitis	0.000237	0.00234	CcSEcCtD
Montelukast—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000236	0.00234	CcSEcCtD
Montelukast—Pain—Triamcinolone—ankylosing spondylitis	0.000235	0.00233	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000231	0.00228	CcSEcCtD
Montelukast—Convulsion—Prednisone—ankylosing spondylitis	0.00023	0.00228	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00023	0.00228	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000227	0.00225	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000227	0.00225	CcSEcCtD
Montelukast—Arthralgia—Prednisone—ankylosing spondylitis	0.000226	0.00224	CcSEcCtD
Montelukast—Myalgia—Prednisone—ankylosing spondylitis	0.000226	0.00224	CcSEcCtD
Montelukast—Anxiety—Prednisone—ankylosing spondylitis	0.000226	0.00223	CcSEcCtD
Montelukast—Insomnia—Betamethasone—ankylosing spondylitis	0.000225	0.00223	CcSEcCtD
Montelukast—Insomnia—Dexamethasone—ankylosing spondylitis	0.000225	0.00223	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000225	0.00223	CcSEcCtD
Montelukast—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000224	0.00222	CcSEcCtD
Montelukast—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000224	0.00222	CcSEcCtD
Montelukast—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000224	0.00222	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—ankylosing spondylitis	0.000224	0.00221	CcSEcCtD
Montelukast—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00022	0.00218	CcSEcCtD
Montelukast—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000219	0.00217	CcSEcCtD
Montelukast—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000219	0.00217	CcSEcCtD
Montelukast—Urticaria—Triamcinolone—ankylosing spondylitis	0.000218	0.00216	CcSEcCtD
Montelukast—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000218	0.00216	CcSEcCtD
Montelukast—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000217	0.00215	CcSEcCtD
Montelukast—Oedema—Prednisone—ankylosing spondylitis	0.000217	0.00215	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000217	0.00215	CcSEcCtD
Montelukast—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000217	0.00214	CcSEcCtD
Montelukast—Infection—Prednisone—ankylosing spondylitis	0.000216	0.00213	CcSEcCtD
Montelukast—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000215	0.00213	CcSEcCtD
Montelukast—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000215	0.00213	CcSEcCtD
Montelukast—Fatigue—Dexamethasone—ankylosing spondylitis	0.000215	0.00213	CcSEcCtD
Montelukast—Fatigue—Betamethasone—ankylosing spondylitis	0.000215	0.00213	CcSEcCtD
Montelukast—Pain—Betamethasone—ankylosing spondylitis	0.000213	0.00211	CcSEcCtD
Montelukast—Pain—Dexamethasone—ankylosing spondylitis	0.000213	0.00211	CcSEcCtD
Montelukast—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000213	0.00211	CcSEcCtD
Montelukast—Skin disorder—Prednisone—ankylosing spondylitis	0.000211	0.00209	CcSEcCtD
Montelukast—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000204	0.00202	CcSEcCtD
Montelukast—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000204	0.00202	CcSEcCtD
Montelukast—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000202	0.002	CcSEcCtD
Montelukast—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000202	0.002	CcSEcCtD
Montelukast—Urticaria—Betamethasone—ankylosing spondylitis	0.000198	0.00196	CcSEcCtD
Montelukast—Urticaria—Dexamethasone—ankylosing spondylitis	0.000198	0.00196	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000198	0.00196	CcSEcCtD
Montelukast—Dizziness—Prednisolone—ankylosing spondylitis	0.000197	0.00196	CcSEcCtD
Montelukast—Asthenia—Triamcinolone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000197	0.00195	CcSEcCtD
Montelukast—Insomnia—Prednisone—ankylosing spondylitis	0.000196	0.00194	CcSEcCtD
Montelukast—Paraesthesia—Prednisone—ankylosing spondylitis	0.000195	0.00193	CcSEcCtD
Montelukast—Pruritus—Triamcinolone—ankylosing spondylitis	0.000194	0.00192	CcSEcCtD
Montelukast—Cough—Methotrexate—ankylosing spondylitis	0.000194	0.00192	CcSEcCtD
Montelukast—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000194	0.00192	CcSEcCtD
Montelukast—Convulsion—Methotrexate—ankylosing spondylitis	0.000193	0.00191	CcSEcCtD
Montelukast—Dyspepsia—Prednisone—ankylosing spondylitis	0.000191	0.00189	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—ankylosing spondylitis	0.000189	0.00187	CcSEcCtD
Montelukast—Myalgia—Methotrexate—ankylosing spondylitis	0.000189	0.00187	CcSEcCtD
Montelukast—Rash—Prednisolone—ankylosing spondylitis	0.000188	0.00186	CcSEcCtD
Montelukast—Dermatitis—Prednisolone—ankylosing spondylitis	0.000188	0.00186	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000188	0.00186	CcSEcCtD
Montelukast—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000187	0.00186	CcSEcCtD
Montelukast—Fatigue—Prednisone—ankylosing spondylitis	0.000187	0.00185	CcSEcCtD
Montelukast—Headache—Prednisolone—ankylosing spondylitis	0.000187	0.00185	CcSEcCtD
Montelukast—Dizziness—Triamcinolone—ankylosing spondylitis	0.000182	0.0018	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000181	0.0018	CcSEcCtD
Montelukast—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000181	0.00179	CcSEcCtD
Montelukast—Infection—Methotrexate—ankylosing spondylitis	0.00018	0.00178	CcSEcCtD
Montelukast—Asthenia—Betamethasone—ankylosing spondylitis	0.000179	0.00177	CcSEcCtD
Montelukast—Asthenia—Dexamethasone—ankylosing spondylitis	0.000179	0.00177	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000178	0.00176	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000178	0.00176	CcSEcCtD
Montelukast—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000177	0.00176	CcSEcCtD
Montelukast—Nausea—Prednisolone—ankylosing spondylitis	0.000177	0.00176	CcSEcCtD
Montelukast—Pruritus—Dexamethasone—ankylosing spondylitis	0.000176	0.00175	CcSEcCtD
Montelukast—Pruritus—Betamethasone—ankylosing spondylitis	0.000176	0.00175	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—ankylosing spondylitis	0.000176	0.00174	CcSEcCtD
Montelukast—Vomiting—Triamcinolone—ankylosing spondylitis	0.000175	0.00173	CcSEcCtD
Montelukast—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000174	0.00173	CcSEcCtD
Montelukast—Rash—Triamcinolone—ankylosing spondylitis	0.000173	0.00171	CcSEcCtD
Montelukast—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000173	0.00171	CcSEcCtD
Montelukast—Rash—Methylprednisolone—ankylosing spondylitis	0.000173	0.00171	CcSEcCtD
Montelukast—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000173	0.00171	CcSEcCtD
Montelukast—Urticaria—Prednisone—ankylosing spondylitis	0.000172	0.00171	CcSEcCtD
Montelukast—Headache—Triamcinolone—ankylosing spondylitis	0.000172	0.0017	CcSEcCtD
Montelukast—Headache—Methylprednisolone—ankylosing spondylitis	0.000172	0.0017	CcSEcCtD
Montelukast—Abdominal pain—Prednisone—ankylosing spondylitis	0.000172	0.0017	CcSEcCtD
Montelukast—Body temperature increased—Prednisone—ankylosing spondylitis	0.000172	0.0017	CcSEcCtD
Montelukast—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00017	0.00169	CcSEcCtD
Montelukast—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00017	0.00169	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000165	0.00164	CcSEcCtD
Montelukast—Dizziness—Betamethasone—ankylosing spondylitis	0.000165	0.00163	CcSEcCtD
Montelukast—Dizziness—Dexamethasone—ankylosing spondylitis	0.000165	0.00163	CcSEcCtD
Montelukast—Insomnia—Methotrexate—ankylosing spondylitis	0.000164	0.00162	CcSEcCtD
Montelukast—Nausea—Triamcinolone—ankylosing spondylitis	0.000163	0.00162	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000163	0.00161	CcSEcCtD
Montelukast—Nausea—Methylprednisolone—ankylosing spondylitis	0.000163	0.00161	CcSEcCtD
Montelukast—Somnolence—Methotrexate—ankylosing spondylitis	0.000161	0.0016	CcSEcCtD
Montelukast—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00016	0.00158	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00016	0.00158	CcSEcCtD
Montelukast—Vomiting—Dexamethasone—ankylosing spondylitis	0.000158	0.00157	CcSEcCtD
Montelukast—Vomiting—Betamethasone—ankylosing spondylitis	0.000158	0.00157	CcSEcCtD
Montelukast—Rash—Betamethasone—ankylosing spondylitis	0.000157	0.00156	CcSEcCtD
Montelukast—Rash—Dexamethasone—ankylosing spondylitis	0.000157	0.00156	CcSEcCtD
Montelukast—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000157	0.00155	CcSEcCtD
Montelukast—Dermatitis—Betamethasone—ankylosing spondylitis	0.000157	0.00155	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000157	0.00155	CcSEcCtD
Montelukast—Fatigue—Methotrexate—ankylosing spondylitis	0.000156	0.00155	CcSEcCtD
Montelukast—Headache—Dexamethasone—ankylosing spondylitis	0.000156	0.00155	CcSEcCtD
Montelukast—Headache—Betamethasone—ankylosing spondylitis	0.000156	0.00155	CcSEcCtD
Montelukast—Asthenia—Prednisone—ankylosing spondylitis	0.000156	0.00154	CcSEcCtD
Montelukast—Pain—Methotrexate—ankylosing spondylitis	0.000155	0.00154	CcSEcCtD
Montelukast—Pruritus—Prednisone—ankylosing spondylitis	0.000154	0.00152	CcSEcCtD
Montelukast—Diarrhoea—Prednisone—ankylosing spondylitis	0.000148	0.00147	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000148	0.00147	CcSEcCtD
Montelukast—Nausea—Betamethasone—ankylosing spondylitis	0.000148	0.00147	CcSEcCtD
Montelukast—Nausea—Dexamethasone—ankylosing spondylitis	0.000148	0.00147	CcSEcCtD
Montelukast—Urticaria—Methotrexate—ankylosing spondylitis	0.000144	0.00143	CcSEcCtD
Montelukast—Dizziness—Prednisone—ankylosing spondylitis	0.000143	0.00142	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000143	0.00142	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000143	0.00142	CcSEcCtD
Montelukast—Vomiting—Prednisone—ankylosing spondylitis	0.000138	0.00137	CcSEcCtD
Montelukast—Rash—Prednisone—ankylosing spondylitis	0.000137	0.00135	CcSEcCtD
Montelukast—Dermatitis—Prednisone—ankylosing spondylitis	0.000137	0.00135	CcSEcCtD
Montelukast—Headache—Prednisone—ankylosing spondylitis	0.000136	0.00135	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000134	0.00132	CcSEcCtD
Montelukast—Asthenia—Methotrexate—ankylosing spondylitis	0.00013	0.00129	CcSEcCtD
Montelukast—Nausea—Prednisone—ankylosing spondylitis	0.000129	0.00128	CcSEcCtD
Montelukast—Pruritus—Methotrexate—ankylosing spondylitis	0.000128	0.00127	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000124	0.00123	CcSEcCtD
Montelukast—Dizziness—Methotrexate—ankylosing spondylitis	0.00012	0.00119	CcSEcCtD
Montelukast—Vomiting—Methotrexate—ankylosing spondylitis	0.000115	0.00114	CcSEcCtD
Montelukast—Rash—Methotrexate—ankylosing spondylitis	0.000114	0.00113	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—ankylosing spondylitis	0.000114	0.00113	CcSEcCtD
Montelukast—Headache—Methotrexate—ankylosing spondylitis	0.000114	0.00112	CcSEcCtD
Montelukast—Nausea—Methotrexate—ankylosing spondylitis	0.000108	0.00107	CcSEcCtD
